Vycor Medical (VYCO) EBITDA (2010 - 2026)
Vycor Medical's (VYCO) quarterly EBITDA came in at $45808.0 in Q1 2026, up 457.71% year-on-year from $8213.6 in Q1 2025, and up 225.42% on a QoQ basis from -$36525.0 in Q4 2025.
Vycor Medical (VYCO) EBITDA (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of EBITDA data on file, last reported at $45808.0 in Q1 2026.
- On a quarterly basis, EBITDA rose 457.71% year-over-year to $45808.0 in Q1 2026; TTM through Mar 2026 was $92514.0, a 844.94% increase from a year earlier, with the FY2025 full-year figure at $33900.0, up 470.69% from the prior year.
- EBITDA for Q1 2026 stood at $45808.0, up from -$36525.0 in the prior quarter.
- Over the last five years, EBITDA for VYCO reached as high as $96520.0 in Q2 2023 and fell as low as -$91196.0 in Q4 2022.
- Historically, EBITDA has averaged -$11515.3 across 5 years, with a median of -$12806.0 in 2025.
- Across the five-year window, EBITDA tumbled 416.63% in 2022 and surged 457.71% in 2026, its largest moves.
- Year by year, EBITDA stood at -$91196.0 in 2022, then climbed by 29.76% to -$64056.0 in 2023, then surged by 130.2% to $19344.0 in 2024, then plunged by 288.82% to -$36525.0 in 2025, then soared by 225.42% to $45808.0 in 2026.
- Per Business Quant data, the three most recent EBITDA figures were $45808.0 in Q1 2026, -$36525.0 in Q4 2025, and $32085.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 45,808.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45,808.00 |
| Dec 31, 2025 | -36,525.00 |
| Sep 30, 2025 | 32,085.00 |
| Jun 30, 2025 | 51,146.00 |
| Mar 31, 2025 | -12,806.00 |
| Dec 31, 2024 | 19,344.00 |
| Sep 30, 2024 | -35,135.00 |
| Jun 30, 2024 | 16,178.00 |
| Mar 31, 2024 | -9,532.00 |
| Dec 31, 2023 | -64,056.00 |
| Sep 30, 2023 | -25,481.00 |
| Jun 30, 2023 | 96,520.00 |
| Mar 31, 2023 | 33,208.00 |
| Dec 31, 2022 | -91,196.00 |
| Sep 30, 2022 | -88,045.00 |
| Jun 30, 2022 | -74,374.00 |
| Mar 31, 2022 | -52,899.00 |
| Dec 31, 2021 | -164,198.00 |
| Sep 30, 2021 | -88,396.00 |
| Jun 30, 2021 | 23,489.00 |